相似文献
1
Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.法国侵袭性肺炎链球菌：2000年至2002年每月全国性研究的抗菌药物耐药性、血清型及分子流行病学研究结果
Antimicrob Agents Chemother. 2004 Sep;48(9):3636-9. doi: 10.1128/AAC.48.9.3636-3639.2004.
2
Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.美国耐左氧氟沙星的侵袭性肺炎链球菌：克隆传播的证据及肺炎球菌结合疫苗的影响
Antimicrob Agents Chemother. 2004 Sep;48(9):3491-7. doi: 10.1128/AAC.48.9.3491-3497.2004.
3
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).意大利耐氟喹诺酮肺炎链球菌菌株的出现与流行病学：哨兵抗菌监测计划（2001 - 2004年）报告
Diagn Microbiol Infect Dis. 2006 Mar;54(3):157-64. doi: 10.1016/j.diagmicrobio.2005.08.012. Epub 2006 Jan 19.
4
Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.2004 - 2005年美国耐抗生素肺炎链球菌的流行病学变化
Clin Infect Dis. 2009 Feb 1;48(3):e23-33. doi: 10.1086/595857.
5
Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.对青霉素具有极高水平耐药性的肺炎链球菌的出现。
Antimicrob Agents Chemother. 2004 Aug;48(8):3016-23. doi: 10.1128/AAC.48.8.3016-3023.2004.
6
[Study of serotype distribution, antimicrobial resistance patterns and molecular epidemiology in 148 isolates of invasive Streptococcus pneumoniae].148株侵袭性肺炎链球菌分离株的血清型分布、耐药模式及分子流行病学研究
Zhonghua Yi Xue Za Zhi. 2010 Jun 8;90(22):1565-70.
7
Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP).亚洲儿童中耐抗生素肺炎球菌的携带情况：亚洲耐药病原体监测网络（ANSORP）的多国监测
Clin Infect Dis. 2001 May 15;32(10):1463-9. doi: 10.1086/320165. Epub 2001 Apr 20.
8
Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology.法国19A血清型肺炎链球菌的出现：分子荚膜血清分型、抗菌药物敏感性及流行病学
Diagn Microbiol Infect Dis. 2009 Sep;65(1):49-57. doi: 10.1016/j.diagmicrobio.2009.05.009.
9
Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.2002年至2004年在东京分离出的肺炎链球菌中β-内酰胺类和大环内酯类抗生素的药敏性及耐药基因分布
Int J Antimicrob Agents. 2007 Jan;29(1):26-33. doi: 10.1016/j.ijantimicag.2006.09.004.
10
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.美国儿童中19A血清型肺炎链球菌的疫苗接种后基因结构
J Infect Dis. 2005 Dec 1;192(11):1988-95. doi: 10.1086/498043. Epub 2005 Nov 1.
引用本文的文献
1
Glycopeptide resistance in gram-positive cocci: a review.革兰氏阳性球菌中的糖肽类耐药性：综述
Interdiscip Perspect Infect Dis. 2012;2012:781679. doi: 10.1155/2012/781679. Epub 2012 Jun 19.
2
In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies.达托霉素对法国从菌血症以及社区获得性皮肤和软组织感染中分离出的葡萄球菌的体外活性：两项全国性研究的数据
Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1209-15. doi: 10.1007/s10096-009-0764-y. Epub 2009 Jun 6.
3
Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France.法国产超广谱β-内酰胺酶肠杆菌科细菌的全国患病率、特征及分子流行病学研究。
Antimicrob Agents Chemother. 2008 Feb;52(2):786-9. doi: 10.1128/AAC.00906-07. Epub 2007 Nov 19.
4
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.多重耐药肺炎链球菌感染：当前及未来的治疗选择
Drugs. 2007;67(16):2355-82. doi: 10.2165/00003495-200767160-00005.
5
Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.在德国，导致成人侵袭性疾病的大环内酯耐药性肺炎链球菌mef阳性分离株的克隆传播。
Antimicrob Agents Chemother. 2007 May;51(5):1830-4. doi: 10.1128/AAC.01453-06. Epub 2007 Feb 26.
6
Vancomycin-tolerant Streptococcus pneumoniae in Korea.韩国的耐万古霉素肺炎链球菌
J Clin Microbiol. 2006 Oct;44(10):3524-8. doi: 10.1128/JCM.00558-06.
7
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.新型酮内酯类药物塞曲霉素在小鼠肺炎模型中对红霉素敏感或耐药的肺炎链球菌的疗效。
Antimicrob Agents Chemother. 2006 Sep;50(9):3033-8. doi: 10.1128/AAC.00920-05.
8
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.葡萄牙11年间侵袭性肺炎链球菌分离株的抗菌药敏情况。
Antimicrob Agents Chemother. 2006 Jun;50(6):2098-105. doi: 10.1128/AAC.00198-06.
9
New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France.采用锁核酸探针的新型实时聚合酶链反应检测法评估法国氟喹诺酮敏感肺炎链球菌分离株中ParC突变的流行情况。
Antimicrob Agents Chemother. 2006 Apr;50(4):1594-8. doi: 10.1128/AAC.50.4.1594-1598.2006.
10
Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.2002年在芬兰收集的肺炎链球菌分离株中大环内酯类耐药的患病率及分子遗传学
Antimicrob Agents Chemother. 2005 Oct;49(10):4180-4. doi: 10.1128/AAC.49.10.4180-4184.2005.
本文引用的文献
1
Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area.对从法国岛地区儿童中分离出的侵袭性肺炎链球菌进行分子流行病学、血清型及抗菌药物敏感性模式的多中心研究。
Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):27-33. doi: 10.1007/s10096-003-1032-1. Epub 2003 Dec 2.
2
Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.肺炎链球菌的抗菌药物敏感性断点及parC基因第一步突变：重新定义氟喹诺酮类耐药性
Emerg Infect Dis. 2003 Jul;9(7):833-7. doi: 10.3201/eid0907.020589.
3
Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001.1999年至2001年在西班牙巴塞罗那分离出的肺炎链球菌菌株中万古霉素耐受性的缺乏。
Antimicrob Agents Chemother. 2003 Jun;47(6):1976-8. doi: 10.1128/AAC.47.6.1976-1978.2003.
4
Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties.法国八个县肺炎链球菌菌血症的临床和微生物学流行病学
Clin Microbiol Infect. 2003 Apr;9(4):280-8. doi: 10.1046/j.1469-0691.2003.00520.x.
5
In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.莫西沙星对法国近期分离出的社区获得性呼吸道病原体的体外活性：一项全国性调查。
Int J Antimicrob Agents. 2002 Sep;20(3):186-95. doi: 10.1016/s0924-8579(02)00161-9.
6
Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children.从法国儿童中分离出的侵袭性肺炎球菌菌株的表型和基因多样性。
J Clin Microbiol. 2002 Aug;40(8):2994-8. doi: 10.1128/JCM.40.8.2994-2998.2002.
7
Global antibiotic resistance in Streptococcus pneumoniae.肺炎链球菌的全球抗生素耐药性
J Antimicrob Chemother. 2002 Jul;50 Suppl:1-5. doi: 10.1093/jac/dkf801.
8
Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance.1995年至1999年丹麦侵袭性肺炎球菌感染：流行病学、血清型及耐药性
Clin Diagn Lab Immunol. 2002 Mar;9(2):358-65. doi: 10.1128/cdli.9.2.358-365.2002.
9
The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.1994 - 2000年美国耐青霉素肺炎链球菌的分子流行病学
Clin Infect Dis. 2002 Feb 1;34(3):330-9. doi: 10.1086/338065. Epub 2001 Dec 17.
10
Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants.评估用于筛选肺炎链球菌分离株和β-内酰胺耐药性以及检测常见大环内酯类耐药决定因素的聚合酶链反应（PCR）引物。
J Antimicrob Chemother. 2001 Dec;48(6):915-8. doi: 10.1093/jac/48.6.915.
Zotero 插件